Biological signatures and prediction of an immunosuppressive status-persistent critical illness-among orthopedic trauma patients using machine learning techniques.

Mingxing Lei, Zhencan Han, Shengjie Wang, Chunxue Guo, Xianlong Zhang, Ya Song, Feng Lin, Tianlong Huang
Author Information
  1. Mingxing Lei: Department of Orthopedic Surgery, Hainan Hospital of Chinese People's Liberation Army (PLA) General Hospital, Sanya, China.
  2. Zhencan Han: Xiangya School of Medicine, Central South University, Changsha, China.
  3. Shengjie Wang: Department of Orthopedic Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University, Shanghai, China.
  4. Chunxue Guo: Department of Biostatistics, Hengpu Yinuo (Beijing) Technology Co., Ltd, Beijing, China.
  5. Xianlong Zhang: Department of Orthopedic Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University, Shanghai, China.
  6. Ya Song: Department of Orthopedic, Xiangya Hospital of Central South University, Changsha, China.
  7. Feng Lin: Department of Orthopedic Surgery, Hainan Hospital of Chinese People's Liberation Army (PLA) General Hospital, Sanya, China.
  8. Tianlong Huang: Department of Orthopedic Surgery, The Second Xiangya Hospital of Central South University, Changsha, China.

Abstract

Background: Persistent critical illness (PerCI) is an immunosuppressive status. The underlying pathophysiology driving PerCI remains incompletely understood. The objectives of the study were to identify the biological signature of PerCI development, and to construct a reliable prediction model for patients who had suffered orthopedic trauma using machine learning techniques.
Methods: This study enrolled 1257 patients from the Medical Information Mart for Intensive Care III (MIMIC-III) database. Lymphocytes were tracked from ICU admission to more than 20 days following admission to examine the dynamic changes over time. Over 40 possible variables were gathered for investigation. Patients were split 80:20 at random into a training cohort (n=1035) and an internal validation cohort (n=222). Four machine learning algorithms, including random forest, gradient boosting machine, decision tree, and support vector machine, and a logistic regression technique were utilized to train and optimize models using data from the training cohort. Patients in the internal validation cohort were used to validate models, and the optimal one was chosen. Patients from two large teaching hospitals were used for external validation (n=113). The key metrics that used to assess the prediction performance of models mainly included discrimination, calibration, and clinical usefulness. To encourage clinical application based on the optimal machine learning-based model, a web-based calculator was developed.
Results: 16.0% (201/1257) of all patients had PerCI in the MIMIC-III database. The means of lymphocytes (%) were consistently below the normal reference range across the time among PerCI patients (around 10.0%), whereas in patients without PerCI, the number of lymphocytes continued to increase and began to be in normal range on day 10 following ICU admission. Subgroup analysis demonstrated that patients with PerCI were in a more serious health condition at admission since those patients had worse nutritional status, more electrolyte imbalance and infection-related comorbidities, and more severe illness scores. Eight variables, including albumin, serum calcium, red cell volume distributing width (RDW), blood pH, heart rate, respiratory failure, pneumonia, and the Sepsis-related Organ Failure Assessment (SOFA) score, were significantly associated with PerCI, according to the least absolute shrinkage and selection operator (LASSO) logistic regression model combined with the 10-fold cross-validation. These variables were all included in the modelling. In comparison to other algorithms, the random forest had the optimal prediction ability with the highest area under receiver operating characteristic (AUROC) (0.823, 95% CI: 0.757-0.889), highest Youden index (1.571), and lowest Brier score (0.107). The AUROC in the external validation cohort was also up to 0.800 (95% CI: 0.688-0.912). Based on the risk stratification system, patients in the high-risk group had a 10.0-time greater chance of developing PerCI than those in the low-risk group. A web-based calculator was available at https://starxueshu-perci-prediction-main-9k8eof.streamlitapp.com/.
Conclusions: Patients with PerCI typically remain in an immunosuppressive status, but those without PerCI gradually regain normal immunity. The dynamic changes of lymphocytes can be a reliable biomarker for PerCI. This work developed a reliable model that may be helpful in improving early diagnosis and targeted intervention of PerCI. Beneficial interventions, such as improving nutritional status and immunity, maintaining electrolyte and acid-base balance, curbing infection, and promoting respiratory recovery, are early warranted to prevent the onset of PerCI, especially among patients in the high-risk group and those with a continuously low level of lymphocytes.

Keywords

References

  1. Eur J Clin Invest. 2015 Dec;45(12):1341-9 [PMID: 26549412]
  2. Injury. 2016 Jul;47(7):1393-403 [PMID: 27157986]
  3. Crit Care Med. 2017 Dec;45(12):1989-1996 [PMID: 28837430]
  4. Crit Care Med. 2015 Feb;43(2):282-7 [PMID: 25377018]
  5. Crit Care Resusc. 2019 Jun;21(2):110-118 [PMID: 31142241]
  6. JAMA. 2017 Oct 10;318(14):1377-1384 [PMID: 29049590]
  7. Methods Mol Biol. 2010;609:223-39 [PMID: 20221922]
  8. Shock. 2018 Mar;49(3):249-258 [PMID: 28885387]
  9. Crit Care Resusc. 2015 Sep;17(3):153-8 [PMID: 26282252]
  10. Crit Care Med. 2017 Feb;45(2):253-262 [PMID: 27632674]
  11. Sci Data. 2016 May 24;3:160035 [PMID: 27219127]
  12. Lancet Respir Med. 2015 Jul;3(7):501-2 [PMID: 26003387]
  13. J Clin Med. 2021 May 25;10(11): [PMID: 34070395]
  14. Am J Respir Crit Care Med. 2010 Aug 15;182(4):446-54 [PMID: 20448093]
  15. Crit Care Clin. 2018 Oct;34(4):493-500 [PMID: 30223989]
  16. Crit Care. 2020 Feb 18;24(1):57 [PMID: 32070393]
  17. Ann Surg. 2021 Oct 1;274(4):664-673 [PMID: 34506322]
  18. Crit Care Resusc. 2015 Sep;17(3):215-8 [PMID: 26282262]
  19. Lancet Respir Med. 2016 Jul;4(7):566-573 [PMID: 27155770]
  20. Br J Anaesth. 2000 Oct;85(4):599-610 [PMID: 11064620]
  21. J Clin Endocrinol Metab. 1998 Feb;83(2):309-19 [PMID: 9467533]
  22. J Crit Care. 2019 Dec;54:250-255 [PMID: 31630075]
  23. Intensive Care Med. 2018 Dec;44(12):2134-2144 [PMID: 30421256]
  24. J Trauma Acute Care Surg. 2012 Jun;72(6):1491-501 [PMID: 22695412]
  25. Intensive Care Med. 2019 May;45(5):709-711 [PMID: 30741331]
  26. J R Stat Soc Series B Stat Methodol. 2012 Mar;74(2):245-266 [PMID: 25506256]
  27. Intensive Care Med. 2020 Aug;46(8):1567-1575 [PMID: 32500182]
  28. Eur J Trauma Emerg Surg. 2022 Apr;48(2):811-825 [PMID: 34302503]
  29. Intensive Care Med. 1996 Jul;22(7):707-10 [PMID: 8844239]
  30. Surgery. 2018 Aug;164(2):178-184 [PMID: 29807651]
  31. JAMA. 2011 Mar 9;305(10):1001-7 [PMID: 21386078]
  32. Intensive Care Med. 2019 Dec;45(12):1718-1731 [PMID: 31531715]
  33. J Crit Care. 2018 Aug;46:55-57 [PMID: 29684773]
  34. Epidemiology. 2010 Jan;21(1):128-38 [PMID: 20010215]
  35. J Trauma Acute Care Surg. 2021 Jan 1;90(1):35-45 [PMID: 33017357]
  36. Shock. 2018 Jan;49(1):4-14 [PMID: 28682945]

MeSH Term

Humans
Critical Illness
Machine Learning
Risk Factors
ROC Curve
Organ Dysfunction Scores

Word Cloud

Created with Highcharts 10.0.0PerCIpatientsmachinecohortlymphocytes0statuspredictionmodellearningadmissionPatientsvalidationcriticalillnessimmunosuppressivereliableusingvariablesrandommodelsusedoptimalnormal10groupstudybiologicalsignatureorthopedictraumatechniquesMIMIC-IIIdatabaseICUfollowingdynamicchangestimetraininginternalalgorithmsincludingforestlogisticregressionexternalincludedclinicalweb-basedcalculatordeveloped0%rangeamongwithoutnutritionalelectrolyterespiratoryscorehighestAUROC95%CI:high-riskimmunityimprovingearlyBackground:PersistentunderlyingpathophysiologydrivingremainsincompletelyunderstoodobjectivesidentifydevelopmentconstructsufferedMethods:enrolled1257MedicalInformationMartIntensiveCareIIILymphocytestracked20daysexamine40possiblegatheredinvestigationsplit80:20n=1035n=222Fourgradientboostingdecisiontreesupportvectortechniqueutilizedtrainoptimizedatavalidateonechosentwolargeteachinghospitalsn=113keymetricsassessperformancemainlydiscriminationcalibrationusefulnessencourageapplicationbasedlearning-basedResults:16201/1257means%consistentlyreferenceacrossaroundwhereasnumbercontinuedincreasebegandaySubgroupanalysisdemonstratedserioushealthconditionsinceworseimbalanceinfection-relatedcomorbiditiesseverescoresEightalbuminserumcalciumredcellvolumedistributingwidthRDWbloodpHheartratefailurepneumoniaSepsis-relatedOrganFailureAssessmentSOFAsignificantlyassociatedaccordingleastabsoluteshrinkageselectionoperatorLASSOcombined10-foldcross-validationmodellingcomparisonabilityareareceiveroperatingcharacteristic823757-0889Youdenindex1571lowestBrier107also800688-0912Basedriskstratificationsystem0-timegreaterchancedevelopinglow-riskavailablehttps://starxueshu-perci-prediction-main-9k8eofstreamlitappcom/Conclusions:typicallyremaingraduallyregaincanbiomarkerworkmayhelpfuldiagnosistargetedinterventionBeneficialinterventionsmaintainingacid-basebalancecurbinginfectionpromotingrecoverywarrantedpreventonsetespeciallycontinuouslylowlevelBiologicalsignaturesstatus-persistentillness-amongimmunosuppressionpersistent

Similar Articles

Cited By